Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adamis Pharma (ADMP)
NASDAQ:ADMP
Holding ADMP?
Track your performance easily
ADMP Stock Chart & Stats
Day’s Range$0.75 - $0.79
52-Week Range― - ―
Previous Close$0.77
Volume119.84K
Average Volume (3M)N/A
Market Cap
$6.97M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 13, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Adamis Pharma News
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ADMP FAQ
What was Adamis Pharma’s price range in the past 12 months?
Currently, no data Available
What is Adamis Pharma’s market cap?
Currently, no data Available
When is Adamis Pharma’s upcoming earnings report date?
Adamis Pharma’s upcoming earnings report date is Nov 13, 2023 which is 312 days ago.
How were Adamis Pharma’s earnings last quarter?
Adamis Pharma released its earnings results on Aug 21, 2023. The company reported -$3.4 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.4.
Is Adamis Pharma overvalued?
According to Wall Street analysts Adamis Pharma’s price is currently Overvalued.
Does Adamis Pharma pay dividends?
Adamis Pharma does not currently pay dividends.
What is Adamis Pharma’s EPS estimate?
Adamis Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adamis Pharma have?
Currently, no data Available
What happened to Adamis Pharma’s price movement after its last earnings report?
Adamis Pharma reported an EPS of -$3.4 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Adamis Pharma?
Among the largest hedge funds holding Adamis Pharma’s share is Greenlight Capital Inc. It holds Adamis Pharma’s shares valued at N/A.
---
Adamis Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 4.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.6%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-96.74%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-73.16%
Trailing 12-Months
Company Description
Adamis Pharma
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
ADMP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---